Security and Addiction Prevention Partner in the Workplace

AMA Prevention – French company based in Strasbourg, specializing in prevention, screening, and safety. Our products and services help businesses, communities, and individuals act against drug use, road risks, and chemical submission. All our tests are CE and ISO 13485 certified, manufactured in Alsace in partnership with Toda Pharma (France’s number 1 in rapid diagnostic testing, UAF label).

Our vision

Our mission: prevent, raise awareness, and protect. AMA Prevention works for a safer society by combining scientific expertise, education, and field commitment. We support companies, associations, and communities in their prevention, screening, and training efforts.

  • More than 250 companies supported since inception.
  • 3,000 tests used weekly in screening campaigns.

Workplace prevention

Preventing risks related to drugs, alcohol, and psychoactive medications is a major challenge. AMA Prevention supports employers in implementing internal safety policies, in accordance with the Plan Joana (2025) and articles L.4121-1 and R.4222-10 of the Labor Code.

  • Training for HR managers, QHSE officers, and supervisors.
  • Raising employee awareness about addictive behaviors.
  • Integrating prevention into the DUERP and post-training follow-up.

Key figures:

  • 1 in 6 workplace accidents is linked to psychoactive substance use (INRS, 2023).
  • 10% of employees report having worked with a colleague under the influence of drugs (Santé publique France, 2024).
  • 85% of companies trained in prevention report a decrease in incidents (INRS, 2024).

All our professional solutions comply with the Council of State decision CE n°394178 of December 5, 2016, which validates the legality and reliability of saliva tests according to the decree of December 13, 2016.

→ Discover the Business space

Road safety

As a partner in road safety prevention, AMA Prevention offers tools and awareness actions aimed at companies, communities, and public events. Our devices help reduce accidents related to substance use.

Key figures:

  • 23% of fatal road accidents involve drug use (Road Safety, 2024).
  • 30% of fatal accidents involve alcohol (ONISR, 2024).
  • 1 in 5 drivers killed tested positive for drugs (ONISR, 2024).

These actions are part of the Plan Joana, which strengthens screenings in road and school transport.

Screening and medical solutions

Our screening solutions are intended for companies, healthcare professionals, and individuals. They allow rapid detection of psychoactive substances in saliva or urine, with a high level of accuracy.

  • Drugdiag® saliva tests – detection of THC, cocaine, amphetamines, MDMA, opiates.
  • Drugdiag® urine tests – multi-drug detection, including 3-MMC, 4-MMC, K2, and UR-144.
  • Tools used by the military, SNCF, municipal police, and large companies.

Key figures:

  • 44% of 17-year-olds have already tried an illicit drug (OFDT, 2024).
  • 3.4 million French people consumed cannabis in the past year (EMCDDA, 2024).
  • 1.2 million use cocaine at least once a year (EMCDDA, 2024).

Festive environment and fight against chemical submission

AMA Prevention is committed to fighting chemical submission and party-related violence. Present on the ground, our team works in partnership with associations such as Projet Artémise and Balance Ton Bar.

Key figures:

  • 1,000 suspected cases of chemical submission recorded in France in 2024 (Santé publique France).
  • 70% involve festive environments or night establishments.
  • 1 in 2 victims is under 25 years old (Ministry of the Interior, 2025).

Our commitment

AMA Prevention works every day for a safer society. We actively support associations engaged against chemical submission, participate in national campaigns, and train hundreds of professionals each year in preventing addictive behaviors.

Our approach: science, education, compliance, and field commitment.

Make a difference. Create preference. Become a reference.

→ Contact us for your training, testing, or support needs.